Amgen Stock Surges Near One-Year High on Strong Earnings
Amgen Inc.'s stock is trading near its one-year high of $447.03, reaching an elevated level in late August 2026. The company's Q2 2026 earnings and guidance have impressed investors, with revenue of $10.05 billion and adjusted earnings of $6.29 per share, both exceeding market expectations.
The strong Q2 earnings beat and raised full-year guidance have underlined the market's confidence in Amgen's execution. The company's revenue grew by 9.5 percent compared to the same quarter a year earlier, with a net margin of 22.95 percent and return on equity of 124.14 percent for the quarter.
Amgen has raised its full-year outlook, calling for adjusted earnings of $22.30 to $23.50 per share, up from the previous range. This guidance is supported by portfolio-wide execution and research analysts currently forecast that Amgen will deliver around $22.92 in earnings per share for the year.